APLNR is involved in ATRA‐induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K‐Akt‐mTOR signaling-Reference-Cited by-同舟云学术

APLNR is involved in ATRA‐induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K‐Akt‐mTOR signaling

Published:2019-08-13 Issue:11 Volume:33 Page:11959-11972
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Liu Yi¹,Liu Qingluan¹,Chen Shumin²,Liu Yijun¹,Huang Yumei¹,Chen Pan³,Li Xiayu⁴,Gao Ge¹,Xu Keqian¹,Fan Songqing⁵,Zeng Zhaoyang⁴,Xiong Wei⁴,Tan Ming⁴⁶,Li Guiyuan⁴,Zhang Wenling¹

Affiliation:

1. Department of Medical Laboratory ScienceThe Third Xiangya HospitalCentral South UniversityChangshaChina

2. Department of HematologyPeking University People's HospitalBeijingChina

3. Hunan Cancer Hospital‐The Affiliated Cancer Hospital of Xiangya School of MedicineCentral South UniversityChangshaChina

4. The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of EducationCancer Research Institute, Central South UniversityChangshaChina

5. Department of PathologyThe Second Xiangya HospitalCentral South UniversityChangshaChina

6. Mitchell Cancer Institute, USAHealth‐University of South AlabamaMobileAlabamaUSA

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.201802416RR

Reference57 articles.

1. Nasopharyngeal carcinoma